Contact TGA: info@tga.gov.au | 1800 020 653 | More contact info Translate | Subscribe

National Coordinating Committee on Therapeutic Goods (NCCTG)

20 July 2012

The National Coordinating Committee on Therapeutic Goods (NCCTG) was established by Order of the Federal Executive Council on 17 March 1971. The 1971 Order was revoked in October 1986 to facilitate the establishment of NCCTG as a committee of the Australian Health Ministers' Advisory Council (AHMAC).

NCCTG terms of reference

The Terms of Reference of the NCCTG are:

  1. To develop, implement and maintain a uniform national approach to the regulations and controls over therapeutic goods and chemicals used by the public
  2. To contribute to projects relevant to the development of uniform regulations and controls over therapeutic goods and chemicals
  3. To share knowledge on matters relevant to the regulation of therapeutic goods and chemicals
  4. To provide policy guidance on amending the Poisons Standard to decision-makers and advisory committees (the Advisory Committee on Medicines Scheduling and the Advisory Committee on Chemicals Scheduling)
  5. To consider and report to the Clinical, Technical and Ethical Principal Committee (CTEPC) on any matter referred to the NCCTG by CTEPC
  6. To report and make recommendations to the Australian Health Ministers' Advisory Council (through CTEPC) on agreed principles and desired outcomes of the regulation of therapeutic goods and chemicals, including the specific health issues related to people of Aboriginal and Torres Strait Islander origin.

NCCTG servicing

The Committee is serviced by the Therapeutic Goods Administration, part of the Australian Government Department of Health and Ageing.

NCCTG membership

The Committee is chaired by the National Manager of the Therapeutic Goods Administration and there is one other Australian Government appointed member (Coordinator of the Monitoring and Compliance Group of the Therapeutic Goods Administration). One member from each State and Territory health authority is appointed by the relevant Minister responsible for the health portfolio of that State or Territory. One member is nominated by the New Zealand Ministry of Health. A delegate may attend meetings in the absence of a member. At the discretion of the chair, a member may invite an observer.

Member terms

There are no fixed terms for members. Neither sitting fees nor any other benefits are paid to members. Members receive fares and travelling allowance for attending meetings from their various health authorities.

NCCTG members

Dr John Skerritt (Chair)
National Manager
Therapeutic Goods Administration

Dr Larry Kelly
Coordinator, Monitoring & Compliance Group
Therapeutic Goods Administration

Mr Bruce Battye (Acting Member)
Deputy Chief Pharmacist
NSW Health Department

Ms Ruth Hay
Director, Medicines Infrastructure and Support
Medication Services Queensland
Clinical and Statewide Services Division
Queensland Health

Mr Matthew McCrone
Chief Officer, Drugs and Poisons Regulation
Department of Health, Victoria

Mr Neil Keen
Chief Pharmacist
Department of Health, Western Australia

Ms Mary Sharpe
Chief Pharmacist
Department of Health and Human Services, Tasmania

Mr Steve Morris
Chief Pharmacist
SA Health

Ms Gay Lavery
Poisons Control
Department of Health and Families, Northern Territory

Ms Vivien Bevan
Chief Pharmacist
ACT Health

Dr Susan Martindale
Medsafe
Ministry of Health, New Zealand

Contacting NCCTG

To contact the NCCTG Secretariat:

Email ncctg@tga.gov.au
Phone +61 2 6232 8623
Postal address The Secretariat
National Coordinating Committee on Therapeutic Goods
Therapeutic Goods Administration
PO Box 100
Woden ACT 2606
Australia

Top of page

Content last updated: Friday, 20 July 2012

Content last reviewed: Friday, 20 July 2012

Web page last updated: Tuesday, 21 August 2012

URL: http://www.tga.gov.au/about/committees-ncctg.htm